國立高雄大學圖資館 |

Language: English

Back

Recent advances and challenges in the treatment of major depressive disorder

Record Type:	Electronic resources : Monograph/item
Title/Author:	Recent advances and challenges in the treatment of major depressive disorderedited by Yong-Ku Kim.
other author:	Kim, Yong-Ku.
Published:	Singapore :Springer Nature Singapore :2024.
Description:	xxi, 426 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Depression, MentalTreatment.
Online resource:	https://doi.org/10.1007/978-981-97-4402-2
ISBN:	9789819744022$q(electronic bk.)

Recent advances and challenges in the treatment of major depressive disorder
Recent advances and challenges in the treatment of major depressive disorder[electronic resource] /edited by Yong-Ku Kim. - Singapore :Springer Nature Singapore :2024. - xxi, 426 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v. 14562214-8019 ;. - Advances in experimental medicine and biology ;946..

Part I. Molecular Biology-based Treatment for Depression -- Chapter 1. Neuroendocrinological Treatment Targets for Depressive Disorder -- Chapter 2. Psychophamacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorder -- Chapter 3. Efficacy, Safety and Tolerability of Psychedelics in Treatment Resistant Depression (TRD) -- Chapter 4. Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme? -- Chapter 5. Induced Pluripotent Stem Cells (iPSC) Technology for Major Depression -- Chapter 6. Combining Complementary and Alternative Medicine (CAM) with Conventional Treatments for Major Depressive Disorder -- Part II. Brain Network-based Treatments for Depression -- Chapter 7. Application of Transcranial Direct and Alternating Current Stimulation (tDCS & tACS) on Major Depressive Disorder -- Chapter 8. Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression -- Chapter 9. Deep Brain Stimulation (DBS) in Treatment-resistant Depression (TRD): Hope and Concern -- Chapter 10. Electroconvulsive Therapy (ECT) in Major Depression: Oldie but Goodie -- Part III. Psychological Intervention based Treatments for Depression -- Chapter 11. Cognitive Behavioral Therapy and Mindfulness-based Cognitive Therapy for Depressive Disorders: Enhancing Access and Tailoring Interventions in Diverse Settings -- Chapter 12. Acceptance and Commitment Therapy for Major Depressive Disorder: Navigating Depression Treatment in Traditional and Digital Settings with Insights from Current Research -- Chapter 13. The Importance of Psychotherapy for Treatment Resistant Depression -- Chapter 14. Personalized Well-Being Therapy (WBT) for Major Depression -- Part IV. Digital Psychiatry based Treatments for Depression -- Chapter 15. The Potential and Challenges of Virtual Reality as an Adjunctive Treatment of Depression Patients -- Chapter 16. The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics -- Chapter 17. Telepsychiatry in the Treatment of Major Depressive Disorders -- Part V. Personalized Precision Treatments for Depression -- Chapter 18. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches -- Chapter 19. Biomarker Guided Tailored Therapy in Major Depression -- Chapter 20. Navigating the Intersection of Technology and Depression Precision Medicine.

This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners.

ISBN: 9789819744022$q(electronic bk.)

Standard No.: 10.1007/978-981-97-4402-2doiSubjects--Topical Terms:

278342
Depression, Mental
--Treatment.

LC Class. No.: RC537

Dewey Class. No.: 616.852706

Recent advances and challenges in the treatment of major depressive disorder
LDR:04680nmm a2200337 a 4500 001 668992
003 DE-He213
005 20240912130247.0
006 m d
007 cr nn 008maaau
008 250120s2024 si s 0 eng d
020 $a 9789819744022$q(electronic bk.)
020 $a 9789819744015$q(paper)
024 7 $a 10.1007/978-981-97-4402-2 $2 doi
035 $a 978-981-97-4402-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC537
072 7 $a PSAN $2 bicssc
072 7 $a SCI089000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 616.852706 $2 23
090 $a RC537 $b .R295 2024
245 0 0 $a Recent advances and challenges in the treatment of major depressive disorder $h [electronic resource] / $c edited by Yong-Ku Kim.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xxi, 426 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 2214-8019 ; $v v. 1456
505 0 $a Part I. Molecular Biology-based Treatment for Depression -- Chapter 1. Neuroendocrinological Treatment Targets for Depressive Disorder -- Chapter 2. Psychophamacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorder -- Chapter 3. Efficacy, Safety and Tolerability of Psychedelics in Treatment Resistant Depression (TRD) -- Chapter 4. Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme? -- Chapter 5. Induced Pluripotent Stem Cells (iPSC) Technology for Major Depression -- Chapter 6. Combining Complementary and Alternative Medicine (CAM) with Conventional Treatments for Major Depressive Disorder -- Part II. Brain Network-based Treatments for Depression -- Chapter 7. Application of Transcranial Direct and Alternating Current Stimulation (tDCS & tACS) on Major Depressive Disorder -- Chapter 8. Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression -- Chapter 9. Deep Brain Stimulation (DBS) in Treatment-resistant Depression (TRD): Hope and Concern -- Chapter 10. Electroconvulsive Therapy (ECT) in Major Depression: Oldie but Goodie -- Part III. Psychological Intervention based Treatments for Depression -- Chapter 11. Cognitive Behavioral Therapy and Mindfulness-based Cognitive Therapy for Depressive Disorders: Enhancing Access and Tailoring Interventions in Diverse Settings -- Chapter 12. Acceptance and Commitment Therapy for Major Depressive Disorder: Navigating Depression Treatment in Traditional and Digital Settings with Insights from Current Research -- Chapter 13. The Importance of Psychotherapy for Treatment Resistant Depression -- Chapter 14. Personalized Well-Being Therapy (WBT) for Major Depression -- Part IV. Digital Psychiatry based Treatments for Depression -- Chapter 15. The Potential and Challenges of Virtual Reality as an Adjunctive Treatment of Depression Patients -- Chapter 16. The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics -- Chapter 17. Telepsychiatry in the Treatment of Major Depressive Disorders -- Part V. Personalized Precision Treatments for Depression -- Chapter 18. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches -- Chapter 19. Biomarker Guided Tailored Therapy in Major Depression -- Chapter 20. Navigating the Intersection of Technology and Depression Precision Medicine.
520 $a This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners.
650 0 $a Depression, Mental $x Treatment. $3 278342
650 1 4 $a Neuroscience. $3 297547
650 2 4 $a Biomedical Research. $3 243625
650 2 4 $a Physiology. $3 192980
650 2 4 $a Clinical Research. $3 911843
700 1 $a Kim, Yong-Ku. $3 805729
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-981-97-4402-2
950 $a Biomedical and Life Sciences (SpringerNature-11642)